Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

Inhaling medicines: delivering drugs to the body through the lungs

Patton, J. S., & Byron, P. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,329 · see citing works

Deaths: final data for 2007.

Xu, J., Kochanek, K. D., Murphy, S. L., & Tejada‐Vera, B. (2010) · PubMed · Cited by 650 · see citing works

The Lungs as a Portal of Entry for Systemic Drug Delivery

Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 564 · see citing works

Nanomedicine in pulmonary delivery

Mansour, H. M., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 486 · see citing works

Drug information handbook

OGILVIE, R. I. (1983) · PubMed Central · Cited by 395 · see citing works

Nanoparticle formulations in pulmonary drug delivery

Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302 · see citing works

Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial

Rijnders, B. J. A., Cornelissen, J. J., Slobbe, L., Becker, M. J., Doorduijn, J. K., Hop, W. C. J., Ruijgrok, E. J., Löwenberg, B., Vulto, A. G., Lugtenburg, P. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586739 · Cited by 284 · see citing works

A Fullerene−Paclitaxel Chemotherapeutic: Synthesis, Characterization, and Study of Biological Activity in Tissue Culture

Zakharian, T. Y., Seryshev, A. B., Sitharaman, B., Gilbert, B. E., Knight, V., & Wilson, L. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0546525 · Cited by 277 · see citing works

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

Heijerman, H. G. M., Westerman, E. M., Conway, S., & Touw, D. J. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.005 · Cited by 264 · see citing works

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

Vyas, S. P., Kannan, M., Jain, S., Mishra, V. K., & Singh, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262 · see citing works

Nanomedicine for respiratory diseases

Pison, U., Welte, T., Giersig, M., & Groneberg, D. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.068 · Cited by 256 · see citing works

Modified-Release Drug Delivery Technology

Rathbone, M. J., Hadgraft, J., & Roberts, M. S. (2007) · Medical Entomology and Zoology · Cited by 245 · see citing works

Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery

Sung, J. C., Padilla, D. J., Garcia‐Contreras, L., VerBerkmoes, J. L., Durbin, D., Peloquin, C. A., Elbert, K. J., Hickey, A. J., & Edwards, D. A. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9894-2 · Cited by 245 · see citing works

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung

Dailey, L. A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., & Seeger, W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.016 · Cited by 220 · see citing works

Formation, characterization, and fate of inhaled drug nanoparticles

Zhang, J., Wu, L., Chan, H., & Watanabe, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.002 · Cited by 210 · see citing works

Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies

Verschraegen, C. F., Gilbert, B. E., Loyer, E. M., Huaringa, A. J., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183 · see citing works

Inhalable microparticles containing large payload of anti-tuberculosis drugs

Muttil, P., Kaur, J. P., Kumar, K., Yadav, A. B., Sharma, R., & Misra, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.06.006 · Cited by 173 · see citing works

Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles

Azarmi, S., TAO, X., Chen, H., Wang, Z., FINLAY, W., Löbenberg, R., & Roa, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.052 · Cited by 169 · see citing works

Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung

Wittgen, B. P. H., Kunst, P. W. A., van der Born, K., van Wijk, A. W., Perkins, W. R., Pilkiewicz, F. G., Perez-Soler, R., Nicholson, S., Peters, G. J., & Postmus, P. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1480 · Cited by 166 · see citing works

Liposomes as drug carriers in cancer chemotherapy

Weinstein, J. N., & Leserman, L. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90035-4 · Cited by 158 · see citing works

Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.

Koshkina, N. V., Waldrep, J. C., Roberts, L., Golunski, E., Melton, S., & Knight, V. (2001) · PubMed · Cited by 154 · see citing works

Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine

Évora, C., Soriano, I., Rogers, R. A., Shakesheff, K. M., Hanes, J. S., & Langer, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00149-1 · Cited by 147 · see citing works

Aerosolized Chemotherapy

Gagnadoux, F., Hureaux, J., Vecellio, L., Urban, T., Pape, A. L., Valo, I., Montharu, J., Leblond, V., Boisdron‐Celle, M., Lerondel, S., et al. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2007.0656 · Cited by 136 · see citing works

Immunosuppressive therapy after human lung transplantation

Knoop, C., Haverich, A., & Fischer, S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00039203 · Cited by 125 · see citing works

Micro- and nanocarrier-mediated lung targeting

Kurmi, B. D., Kayat, J., Gajbhiye, V., Tekade, R. K., & Jain, N. K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.492212 · Cited by 122 · see citing works

Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation

Changsan, N., Chan, H., Separovic, F., & Srichana, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21441 · Cited by 108 · see citing works

Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer

Otterson, G. A., Villalona-Calero, M. A., Hicks, W. J., Pan, X. J., Ellerton, J. A., Gettinger, S. N., & Murren, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3015 · Cited by 108 · see citing works

Co-spray-dried mannitol–ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

Adi, H., Young, P. M., Chan, H., Agus, H., & Traini, D. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.020 · Cited by 107 · see citing works

Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-lipsomal (Fungizone) amphotericin B in murine pulmonary aspergillosis

Allen, S. D., Sorensen, K. N., Neial, M. J., Durrant, C., & Proffitt, R. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.6.1001 · Cited by 105 · see citing works

Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers

Saari, M., Vidgren, M. T., Koskinen, M. O., Turjanmaa, V., & Nieminen, M. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00398-6 · Cited by 105 · see citing works

Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone

Chougule, M. B., Padhi, B. K., & Misra, A. R. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-007-9024-6 · Cited by 104 · see citing works

Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

Okusanya, Ó. O., Bhavnani, S. M., Hammel, J., Minic, P. B., Dupont, L., Forrest, A., Mulder, G.-J., Mackinson, C., Ambrose, P. G., & Gupta, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00872-08 · Cited by 104 · see citing works

No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes

Canonico, A. E., Plitman, J. D., Conary, J. T., Meyrick, B. O., & Brigham, K. L. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.1.415 · Cited by 103 · see citing works

Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

Knight, V., Koshkina, N. V., Waldrep, J. C., Giovanella, B. C., & Gilbert, B. E. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050965 · Cited by 102 · see citing works

9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.

Koshkina, N. V., Kleinerman, E. S., Waidrep, C., Jia, S.-F., Worth, L. L., Gilbert, B. E., & Knight, V. (2000) · PubMed · Cited by 101 · see citing works

Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages

Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100 · see citing works

Recent advances in liposomal dry powder formulations: preparation and evaluation

Misra, A. R., Jinturkar, K., Patel, D. H., Lalani, J., & Chougule, M. B. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802652309 · Cited by 99 · see citing works

A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers

Weers, J. G., Metzheiser, B., Taylor, G., Warren, S., Meers, P. R., & Perkins, W. R. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0693 · Cited by 98 · see citing works

Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics.

Chougule, M. B., Padhi, B. K., & Misra, A. R. (2007) · PubMed Central · Cited by 97 · see citing works

Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion

Abu‐Dahab, R., Schäfer, U. F., & Lehr, C. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00147-6 · Cited by 95 · see citing works

Budesonide Nanoparticle Agglomerates as Dry Powder Aerosols With Rapid Dissolution

El-Gendy, N. A., Gorman, E. M., Munson, E. J., & Berkland, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21630 · Cited by 90 · see citing works

Phospholipid dry powders produced by spray drying processing: structural, thermodynamic and physical properties

Alves, G. P., & Santana, M. H. A. (2004) · Powder Technology · doi:10.1016/j.powtec.2004.06.008 · Cited by 85 · see citing works

Liposomal dry powders as aerosols for pulmonary delivery of proteins

Lu, D., & Hickey, A. J. (2005) · AAPS PharmSciTech · doi:10.1208/pt060480 · Cited by 85 · see citing works

Acute Effects of Liposome Aerosol Inhalation on Pulmonary Function in Healthy Human Volunteers

Thomas, D. A., Myers, M. A., Wichert, B. M., Schreier, H., & Gonzalez‐Rothi, R. J. (1991) · CHEST Journal · doi:10.1378/chest.99.5.1268 · Cited by 83 · see citing works

Regional Lung Deposition and Clearance of 99mTc-Labeled Beclomethasone-DLPC Liposomes in Mild and Severe Asthma

Saari, S. M., Vidgren, M. T., Koskinen, M. O., Turjanmaa, V., Waldrep, J. C., & Nieminen, M. M. (1998) · CHEST Journal · doi:10.1378/chest.113.6.1573 · Cited by 82 · see citing works

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

Lowry, C. M., Marty, F. M., Vargas, S. O., Lee, J. T., Fiumara, K., Deykin, A., & Baden, L. R. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00209.x · Cited by 82 · see citing works

In vitro evaluation of inhalable isoniazid‐loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis

Chimote, G., & Banerjee, R. (2010) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31608 · Cited by 75 · see citing works

Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation

Behr, J., Zimmermann, G., Baumgartner, R., Leuchte, H. H., Neurohr, C., Brand, P., Herpich, C., Sommerer, K., Seitz, J., Menges, G., et al. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0714 · Cited by 74 · see citing works

Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model

Wijagkanalan, W., Higuchi, Y., Kawakami, S., Teshima, M., Sasaki, H., & Hashida, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050153 · Cited by 74 · see citing works

Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages:in vitroandin vivoevaluation

Zaru, M., Sinico, C., Logu, A. D., Caddeo, C., Lai, F., Manca, M. L., & Fadda, A. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100802610835 · Cited by 73 · see citing works

Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization

Joshi, M., & Misra, A. R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00705-0 · Cited by 72 · see citing works

Pulmonary Effects of Chronic Exposure to Liposome Aerosols in Mice

Myers, M. A., Thomas, D. A., Straub, L., Soucy, D. W., Niven, R. W., Kaltenbach, M. L., Hood, C. I., Schreier, H., & Gonzalez‐Rothi, R. J. (1993) · Experimental Lung Research · doi:10.3109/01902149309071077 · Cited by 72 · see citing works

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery

Kalantarian, P. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12415 · Cited by 70 · see citing works

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis

El-Ridy, M. S., Mostafa, D. M., Shehab, A., Nasr, E. A. A., & El-Alim, S. H. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.017 · Cited by 70 · see citing works

Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy.

McLachlan, G., Davidson, D. J., Stevenson, B. J., Dickinson, P., Davidson‐Smith, H., Dorin, J. R., & Porteous, D. J. (1995) · PubMed · Cited by 68 · see citing works

Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes.

Debs, R. J., Straubinger, R. M., Brunette, E. N., Lin, J. M., Lin, E. J., Montgomery, A., Friend, D. S., & Papahadjopoulos, D. (1987) · PubMed · doi:10.1164/arrd.1987.135.3.731 · Cited by 68 · see citing works

Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug

Sethuraman, V. V., & Hickey, A. J. (2002) · AAPS PharmSciTech · doi:10.1208/pt030428 · Cited by 68 · see citing works

A Receptor-targeted Nanocomplex Vector System Optimized for Respiratory Gene Transfer

Tagalakis, A. D., McAnulty, R. J., Devaney, J., Bottoms, S. E., Wong, J. B., Elbs, M., Writer, M. J., Hailes, H. C., Tabor, A. B., O’Callaghan, C., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.38 · Cited by 66 · see citing works

Relationships between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers and Monolayers at the Air−Water Interface

Mansour, H. M., & Zografi, G. (2007) · Langmuir · doi:10.1021/la063053o · Cited by 65 · see citing works

Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice

Koshkina, N. V., Golunski, E., Roberts, L., Gilbert, B. E., & Knight, V. (2004) · Journal of Aerosol Medicine · doi:10.1089/089426804322994415 · Cited by 64 · see citing works

Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients

Corcoran, T. E., Venkataramanan, R., Mihelc, K. M., Marcinkowski, A. L., Ou, J., McCook, B., Weber, L., Carey, M. E., Paterson, D. L., Pilewski, J. M., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01529.x · Cited by 64 · see citing works

Inhalable liposomal formulation for vasoactive intestinal peptide

Hajos, F., Stark, B., Hensler, S., Prassl, R., & Mosgoeller, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.046 · Cited by 64 · see citing works

Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis

Lawson, K. A., Anderson, K., Snyder, R. M., Simmons-Menchaca, M., Atkinson, J., Sun, L., Bandyopadhyay, A. M., Knight, V., Gilbert, B. E., Sanders, B. G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0817-y · Cited by 62 · see citing works

Development of Budesonide Microparticles Using Spray-Drying Technology for Pulmonary Administration: Design, Characterization, In Vitro Evaluation, and In Vivo Efficacy Study

Naikwade, S. R., Bajaj, A., Gurav, P. B., Gatne, M. M., & Soni, P. S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9290-6 · Cited by 59 · see citing works

Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer

Zou, Y., Zong, G., Ling, Y., & Perez-Soler, R. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700156 · Cited by 59 · see citing works

Proteases implicated in apoptosis: old and new

Moffitt, K. L., Martin, L., & Walker, B. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.05.0002 · Cited by 54 · see citing works

Liposome-based drug delivery to alveolar macrophages

Vyas, S. P., & Khatri, K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.95 · Cited by 52 · see citing works

Liposomes for Drug Delivery to the Respiratory Tract

Taylor, K. M. G., & Fan, S. J. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309038764 · Cited by 52 · see citing works

A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling

Desai, T. R., Wong, J. P., Hancock, R. E. W., & Finlay, W. H. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10021 · Cited by 51 · see citing works

Development of Liposomal Amphotericin B Dry Powder Inhaler Formulation

Shah, S. P., & Misra, A. R. (2004) · Drug Delivery · doi:10.1080/10717540490467375 · Cited by 50 · see citing works

Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol

Mansour, H. M., Wang, D.-S., Chen, C., & Zografi, G. (2001) · Langmuir · doi:10.1021/la0108454 · Cited by 49 · see citing works

Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes

Wyde, P. R., Six, H. R., Wilson, S. Z., Gilbert, B. E., & Knight, V. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.890 · Cited by 48 · see citing works

Aerosol delivery of liposomal all- trans -retinoic acid to the lungs

Parthasarathy, R. V., Gilbert, B. E., & Mehta, K. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050895 · Cited by 48 · see citing works

Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies

Carvalho, T. C., Carvalho, S. R., & McConville, J. T. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0794 · Cited by 47 · see citing works

Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary Tumor Burden and Metastases

Latimer, P., Simmons-Menchaca, M., Snyder, R. M., Yu, W., Gilbert, B. E., Sanders, B. G., & Kline, K. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-rm-8 · Cited by 47 · see citing works

The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions

Mansour, H. M., & Zografi, G. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20810 · Cited by 44 · see citing works

Monitoring safety of liposomes containing rifampicin on respiratory cell lines andin vitroefficacy againstMycobacterium bovisin alveolar macrophages

Changsan, N., Nilkaeo, A., Pungrassami, P., & Srichana, T. (2009) · Journal of drug targeting · doi:10.3109/10611860903079462 · Cited by 42 · see citing works

Cyclosporin A liposome aerosol: Particle size and calculated respiratory deposition

Waldrep, J. C., Scherer, P. W., Keyhani, K., & Knight, V. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90140-b · Cited by 42 · see citing works

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin

Gautam, A. K., Waldrep, J. C., Densmore, C. L., Koshkina, N. V., Melton, S., Roberts, L., Gilbert, B. E., & Knight, V. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301662 · Cited by 42 · see citing works

Evaluation of antitubercular drug‐loaded surfactants as inhalable drug‐delivery systems for pulmonary tuberculosis

Chimote, G., & Banerjee, R. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31959 · Cited by 41 · see citing works

Pulmonary Targeting of Nanoparticle Drug Matrices

Dandekar, P., Venkataraman, C., & Mehra, A. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0784 · Cited by 39 · see citing works

Liposomal Aerosols in the Management of Pulmonary Infections

Gilbert, B. E. (1996) · Journal of Aerosol Medicine · doi:10.1089/jam.1996.9.111 · Cited by 38 · see citing works

Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial

Slobbe, L., Boersma, E. H., & Rijnders, B. J. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.09.001 · Cited by 38 · see citing works

Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation

Gibbons, A., McElvaney, N. G., Taggart, C. C., & Cryan, S. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802466535 · Cited by 36 · see citing works

Pulmonary disposition of budesonide from liposomal dry prowder inhaler

Joshi, M., & Nisra, A. N. (2001) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2001.23.10.677118 · Cited by 36 · see citing works

A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation

Gibbons, A., McElvaney, N. G., & Cryan, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9500-2 · Cited by 35 · see citing works

Spray-Drying of liposomes for a Pulmonary Administration. I. Chemical Stability of Phospholipids

Goldbach, P., Brochart, H., & Stamm, A. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309047204 · Cited by 34 · see citing works

Nano-Liposomal Dry Powder Inhaler of Amiloride Hydrochloride

Chougule, M. B., Padhi, B. K., & Misra, A. R. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.405 · Cited by 34 · see citing works

Effect of Phospholipid Composition on Characterization of Liposomes Containing 9-Nitrocamptothecin

Chen, J., Ping, Q., Guo, J. X., Chu, X.-Z., & Song, M. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500529077 · Cited by 32 · see citing works

Nanopharmaceuticals I: nanocarrier systems in drug delivery

Rhee, Y. S., & Mansour, H. M. (2010) · International Journal of Nanotechnology · doi:10.1504/ijnt.2011.037172 · Cited by 31 · see citing works

Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids

SAARI, S. M., Vidgren, M. T., Herrala, J., Turjanmaa, V., Koskinen, M. O., & Nieminen, M. M. (2002) · Respiratory Medicine · doi:10.1053/rmed.2002.1393 · Cited by 29 · see citing works

Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols

Hickey, A. J. (2002) · CRC Press eBooks · doi:10.1201/9780203910337-73 · Cited by 29 · see citing works

Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung

Joshi, M., & Misra, A. R. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03813.x · Cited by 28 · see citing works

Lipids in Nanotechnology

(2012) · Elsevier eBooks · doi:10.1016/c2015-0-02410-8 · Cited by 28 · see citing works

Chitosan-coated antifungal formulations for nebulisation

Albasarah, Y. Y., Somavarapu, S., Stapleton, P. D., & Taylor, K. M. G. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.07.0002 · Cited by 28 · see citing works

The deposition and clearance of liposome entrapped 99mTc-DTPA in the human respiratory tract

Barker, S. A., Taylor, K. M. G., & Short, M. D. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90051-5 · Cited by 27 · see citing works

Development of Liposomal Salbutamol Sulfate Dry Powder Inhaler Formulation

Huang, W., Yang, Z., Wu, H., Wong, Y.-F., Zhao, Z., & Liu, L. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.512 · Cited by 26 · see citing works

Experimental pulmonary delivery of cyclosporin A by liposome aerosol

Waldrep, J. C., Arppe, J., Jansa, K., & Vidgren, M. T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00322-0 · Cited by 25 · see citing works

CHARACTERIZATION AND ADMINISTRATION OF CYCLOSPORINE LIPOSOMES AS A SMALL-PARTICLE AEROSOL

Gilbert, B. E., Wilson, S. Z., Garçon, N., Wyde, P. R., & Knight, V. (1993) · Transplantation · doi:10.1097/00007890-199310000-00037 · Cited by 24 · see citing works

Efficacy of Combination Antifungal Therapy with Intraperitoneally Administered Micafungin and Aerosolized Liposomal Amphotericin B against Murine Invasive Pulmonary Aspergillosis

Takazono, T., Izumikawa, K., Mihara, T., Kosai, K., Saijo, T., Imamura, Y., Miyazaki, T., Seki, M., Kakeya, H., Yamamoto, Y., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-09 · Cited by 23 · see citing works

Nanopharmaceuticals II: application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine

Wu, X. Y., & Mansour, H. M. (2010) · International Journal of Nanotechnology · doi:10.1504/ijnt.2011.037173 · Cited by 23 · see citing works

Spray-Drying of Liposomes for a Pulmonary Administration. II. Retention of Encapsulated Materials

Goldbach, P., Brochart, H., & Stamm, A. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309047205 · Cited by 21 · see citing works

High dose cyclosporin A and budesonide-liposome aerosols.

Waldrep, J. C., Arppe, J., Jansa, K., & Knight, V. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04912-0 · Cited by 21 · see citing works

Budesonide/formoterol combination in COPD: a US perspective

Sharafkhaneh, A. (2010) · International Journal of COPD · doi:10.2147/copd.s4215 · Cited by 21 · see citing works

Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols

Hickey, A. J., & Mansour, H. M. (2008) · CRC Press eBooks · doi:10.3109/9781420045260-44 · Cited by 21 · see citing works

Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air−Water Interface: Implications for Pulmonary Surfactant Delivery

Mansour, H. M., Damodaran, S., & Zografi, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700123p · Cited by 17 · see citing works

LIPID NANOPARTICULATE DRUG DELIVERY AND NANOMEDICINE

Mansour, H. M., Rhee, Y.-S., Park, C., & DeLuca, P. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-9818936-7-9.50012-3 · Cited by 17 · see citing works

Differential Behaviour of Fluid Liposomes Toward Mammalian Epithelial Cells and Bacteria: Restriction of Fusion to Bacteria

Desjardins, A., Chen, T., Khalil, H., Sayasith, K., & Lagacé, J. (2002) · Journal of drug targeting · doi:10.1080/10611860290007522 · Cited by 16 · see citing works

An alternative aerosol delivery system for amiloride.

Everard, M. L., Devadason, S. G., Sunderland, V. B., & Souëf, P. N. L. (1995) · Thorax · doi:10.1136/thx.50.5.517 · Cited by 15 · see citing works

Liposomes as a Carrier for Pulmonary Delivery of Peptides and Proteins

Bi, R., & Zhang, N. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.050 · Cited by 15 · see citing works

Nebulized Liposomal Amphotericin B and Combined Systemic Antifungal Therapy for the Treatment of Severe Pulmonary Aspergillosis after Allogeneic Hematopoietic Stem Cell Transplant for a Fatal Mitochondrial Disorder

Castagnola, E., Moresco, L., Cappelli, B., Cuzzubbo, D., Moroni, C., Lanino, E., & Faraci, M. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.3.339 · Cited by 13 · see citing works

Pulmonary inhalation aerosols for targeted antibiotics drug delivery

Park, C., Mansour, H. M., & Hayes, D. (2011) · Cited by 13 · see citing works

Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.

Ross, H. J., Canada, A. L., & Slater, L. M. (1997) · PubMed · Cited by 12 · see citing works

Comprar Drug Information Handbook with International Brand Names Index | Charles F. Lacy | 9781591952312 | Lexi-Comp Inc

Lacy, C. F., Armstrong, L. L., Goldman, M., & Lance, L. L. (2008) · Cited by 10 · see citing works

Lipids in nanotechnology

Ahmad, M. (2012) · Cited by 6 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Nanoparticle-Mediated Pulmonary Drug Delivery: A Review

Paranjpe, M., & Müller-Goymann, C. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 454 · see citing works

Delivery strategies for sustained drug release in the lungs

Loira-Pastoriza, C., Todoroff, J., & Rita Vanbever, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 395 · see citing works

Nanotechnology approaches for inhalation treatment of lung diseases

Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 356 · see citing works

Technological and practical challenges of dry powder inhalers and formulations

Hoppentocht, M., Hagedoorn, P., Frijlink, H. W., & de Boer, A. H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.004 · Cited by 304 · see citing works

A materials-science perspective on tackling COVID-19

Tang, Z., Kong, N., Zhang, X., Liu, Y., Hu, P., Mou, S., Liljeström, P., Shi, J., Tan, W., Kim, J. S., et al. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00247-y · Cited by 302 · see citing works

Dry powder inhalation: past, present and future

de Boer, A. H., Hagedoorn, P., Hoppentocht, M., Buttini, F., Grasmeijer, F., & Frijlink, H. W. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1224846 · Cited by 272 · see citing works

Dry powders for oral inhalation free of lactose carrier particles

Healy, A. M., Amaro, M. I., Paluch, K. J., & Tajber, L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.005 · Cited by 235 · see citing works

Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation

Zhang, J., Yang, W., Vo, A. Q., Feng, X., Ye, X., Kim, D. W., & Repka, M. A. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.08.058 · Cited by 211 · see citing works

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Kaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 192 · see citing works

Emerging inhalation aerosol devices and strategies: Where are we headed?

Zhou, Q. T., Tang, P., Leung, S. S. Y., Chan, J. G. Y., & Chan, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.006 · Cited by 190 · see citing works

Pulmonary drug delivery systems for tuberculosis treatment

Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185 · see citing works

Barrier or carrier? Pulmonary surfactant and drug delivery

Hidalgo, A., Cruz, A., & Pérez‐Gil, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.014 · Cited by 184 · see citing works

Liposomal Formulations for Inhalation

Cipolla, D. C., Gonda, I., & Chan, H. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.71 · Cited by 153 · see citing works

Formulation Design of Dry Powders for Inhalation

Weers, J. G., & Miller, D. P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24574 · Cited by 137 · see citing works

Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies

d’Angelo, I., Conte, C., Rotonda, M. I. L., Miro, A., Quaglia, F., & Ungaro, F. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.008 · Cited by 136 · see citing works

Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance

Mehta, P. P., Ghoshal, D., Pawar, A., Kadam, S. S., & Dhapte-Pawar, V. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101509 · Cited by 128 · see citing works

The formulation of nanomedicines for treating tuberculosis

Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.038 · Cited by 119 · see citing works

Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review

Xu, Y., Liu, H., & Song, L. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00703-5 · Cited by 104 · see citing works

The influence of nanoparticulate drug delivery systems in drug therapy

Aminu, N., Bello, I., Umar, N. M., Tanko, N., Aminu, A., & Audu, M. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101961 · Cited by 99 · see citing works

Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy

Li, Y., Yang, J., Gu, G., Guo, X., He, C., Sun, J., Zou, H., Wang, H., Liu, S., Li, X., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.1c03786 · Cited by 95 · see citing works

Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols

Park, C., Li, X., Vogt, F. G., Hayes, D., Zwischenberger, J. B., Park, E., & Mansour, H. M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.047 · Cited by 94 · see citing works

Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies

Osman, N., Kaneko, K., Carini, V., & Saleem, I. Y. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1502267 · Cited by 93 · see citing works

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis

Velino, C., Carella, F., Adamiano, A., Sanguinetti, M., Vitali, A., Catalucci, D., Bugli, F., & Iafisco, M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00406 · Cited by 95 · see citing works

Dry powder inhalers in COPD, lung inflammation and pulmonary infections

Muralidharan, P., Hayes, D., & Mansour, H. M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.977783 · Cited by 91 · see citing works

Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: In vitro and in vivo studies

Jyoti, K., Kaur, K., Pandey, R. S., Jain, U. K., Chandra, R., & Madan, J. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.12.092 · Cited by 82 · see citing works

Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols

Mansour, H. M., Meenach, S. A., Vogt, McGarry, Anderson, �., & Hilt, J. Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30724 · Cited by 77 · see citing works

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers

Muralidharan, P., Mallory, E. K., Malapit, M., Hayes, D., & Mansour, H. M. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6020333 · Cited by 76 · see citing works

Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases

Leo, V. D., Ruscigno, S., Trapani, A., Gioia, S. D., Milano, F., Mandracchia, D., Comparelli, R., Castellani, S., Agostiano, A., Trapani, G., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.030 · Cited by 73 · see citing works

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases

Kole, E. B., Jadhav, K., Shirsath, N. R., Dudhe, P. B., Verma, R. K., Chatterjee, A., & Naik, J. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104261 · Cited by 73 · see citing works

Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation

Khatib, I., Khanal, D., Ruan, J., Cipolla, D. C., Dayton, F., Blanchard, J. D., & Chan, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.068 · Cited by 71 · see citing works

A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications

Shahin, H. I., & Chablani, L. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104553 · Cited by 70 · see citing works

High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

Meenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0182-z · Cited by 69 · see citing works

Towards understanding the antibacterial activity of Ag nanoparticles: electron microscopy in the analysis of the materials-biology interface in the lung

Heras, I. L., Theodorou, I. G., Leo, B. F., Ryan, M. P., & Porter, A. E. (2015) · Environmental Science Nano · doi:10.1039/c5en00051c · Cited by 67 · see citing works

Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway

Muralidharan, P., Hayes, D., Black, S. M., & Mansour, H. M. (2016) · Molecular Systems Design & Engineering · doi:10.1039/c5me00004a · Cited by 62 · see citing works

Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases

Passi, M., Shahid, S., Chockalingam, S., Sundar, I. K., & Packirisamy, G. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s242516 · Cited by 65 · see citing works

Polylactic Acid—Lemongrass Essential Oil Nanocapsules with Antimicrobial Properties

Liakos, I., Grumezescu, A. M., Holban, A. M., Iordache, F., D’Autilia, F., Carzino, R., Bianchini, P., & Athanassiou, A. (2016) · Pharmaceuticals · doi:10.3390/ph9030042 · Cited by 62 · see citing works

Phospholipids in pulmonary drug delivery

Wauthoz, N., & Amighi, K. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201300368 · Cited by 60 · see citing works

Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery

Mansour, H. M., Duan, Vogt, Li, & Hayes, D. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s48631 · Cited by 59 · see citing works

Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection

Alhariri, M., & Omri, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01634-12 · Cited by 59 · see citing works

Emerging aerosol drug delivery strategies: From bench to clinic

Rubin, B. K., & Williams, R. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.008 · Cited by 57 · see citing works

Inhalable clarithromycin liposomal dry powders using ultrasonic spray freeze drying

Ye, T., Yu, J., Luo, Q., Wang, S., & Chan, H. (2016) · Powder Technology · doi:10.1016/j.powtec.2016.09.053 · Cited by 58 · see citing works

Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery

Mansour, H. M., Wu, W., Zhang, & Hayes, D. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40904 · Cited by 53 · see citing works

Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics

Dabbagh, A., Kasim, N. H. A., Yeong, C. H., Wong, T. W., & Rahman, N. A. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2017.1382 · Cited by 52 · see citing works

Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa : A Comparative Study

Derbali, R. M., Aoun, V., Moussa, G., Frei, G., Tehrani, S. F., Orto, J. C. D., Hildgen, P., Roullin, G., & Chain, J. L. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01256 · Cited by 52 · see citing works

Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition

Zara, D. L., Sun, F., Zhang, F., Franek, F., Sivars, K. B., Horndahl, J., Bates, S. M., Brännström, M., Ewing, P., Quayle, M. J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10040 · Cited by 51 · see citing works

Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: Development, in vitro characterization and antioxidant activity

Ourique, A. F., Chaves, P. D. S., Souto, G. D., Pohlmann, A. R., Guterres, S. S., & Beck, R. C. R. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.09.017 · Cited by 51 · see citing works

Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation

Mansour, H. M., Wu, Hayes, D., Zwischenberger, & Kuhn, R. J. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s40166 · Cited by 50 · see citing works

Role of Novel Drug Delivery Vehicles in Nanobiomedicine

Tyagi, R. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77468 · Cited by 51 · see citing works

Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery

Gomez, A. I., Acosta, M. F., Muralidharan, P., Yuan, J. X. ‐., Black, S. M., Hayes, D., & Mansour, H. M. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2020.101975 · Cited by 44 · see citing works

Current views in chronic obstructive pulmonary disease pathogenesis and management

Alfahad, A. J., Alzaydi, M. M., Aldossary, A. M., Alshehri, A. A., Almughem, F. A., Zaidan, N. M., & Tawfik, E. A. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.10.008 · Cited by 46 · see citing works

Inhalable liposomes ofGlycyrrhiza glabraextract for use in tuberculosis: formulation,in vitrocharacterization,in vivolung deposition, andin vivopharmacodynamic studies

Viswanathan, V., Pharande, R. R., Bannalikar, A. S., Gupta, P., Gupta, U. D., & Mukne, A. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1513025 · Cited by 43 · see citing works

Loco-regional administration of nanomedicines for the treatment of lung cancer

Pereira, G. G., Lawson, A. J., Buttini, F., & Sonvico, F. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1114047 · Cited by 42 · see citing works

Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery

Miranda, M. S., Rodrigues, M. T., Domingues, R. M. A., Torrado, E., Reis, R. L., Pedrosa, J., & Gomes, M. E. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.09.004 · Cited by 42 · see citing works

Nanoparticle transport and deposition in a heterogeneous human lung airway tree: An efficient one path model for CFD simulations

Rahman, M. M., Zhao, M., Islam, M. S., Dong, K., & Saha, S. C. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106279 · Cited by 42 · see citing works

A drift on liposomes to proliposomes: recent advances and promising approaches

Dhiman, N., Sarvaiya, J., & Mohindroo, P. (2022) · Journal of Liposome Research · doi:10.1080/08982104.2021.2019762 · Cited by 40 · see citing works

Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases

Ferguson, L. T., Ma, X., Myerson, J. W., Wu, J., Glassman, P. M., Zamora, M. E., Hood, E. D., Zaleski, M. H., Shen, M., Essien, E., et al. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200106 · Cited by 40 · see citing works

Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles

Leung, S. S. Y., Wong, J., Guerra, H. V., Samnick, K., Prud’homme, R. K., & Chan, H. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0039-3 · Cited by 36 · see citing works

Nanocarrier-Based Approaches to Combat Chronic Obstructive Pulmonary Disease

Virmani, T., Kumar, G., Virmani, R., Sharma, A., & Pathak, K. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0403 · Cited by 35 · see citing works

Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model

Reed, M. D., Tellez, C. S., Grimes, M. J., Picchi, M. A., Tessema, M., Cheng, Y. S., March, T. H., Kuehl, P. J., & Belinsky, S. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.575 · Cited by 34 · see citing works

Therapeutic nanostructures for pulmonary drug delivery

Javadzadeh, Y., & Yaqoubi, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00020-8 · Cited by 35 · see citing works

Dry powder inhalers of antitubercular drugs

Nainwal, N., Sharma, Y., & Jakhmola, V. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102228 · Cited by 34 · see citing works

Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research

Al-Lawati, H., Aliabadi, H. M., Makhmalzadeh, B. S., & Lavasanifar, A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1420053 · Cited by 32 · see citing works

Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation

Khatib, I., Tang, P., Ruan, J., Cipolla, D. C., Dayton, F., Blanchard, J. D., & Chan, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119045 · Cited by 29 · see citing works

Nano‐in‐Microparticles for Aerosol Delivery of Antibiotic‐Loaded, Fucose‐Derivatized, and Macrophage‐Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery

Huck, B. C., Thiyagarajan, D., Bali, A., Boese, A. S., Besecke, K. F. W., Hozsa, C., Gieseler, R. K. H., Furch, M., Carvalho‐Wodarz, C. D. S., Waldow, F., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102117 · Cited by 29 · see citing works

Liposomes-and niosomes-based drug delivery systems for tuberculosis treatment

Bekraki, A. I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00007-2 · Cited by 28 · see citing works

Inhalable nanomedicine for lung cancer treatment

Zhang, S., Li, R., Jiang, T., Gao, Y., Zhong, K., Cheng, H. B., Chen, X., & Li, S. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.04.001 · Cited by 26 · see citing works

Liposomal Antibiotic Formulations for Targeting the Lungs in the Treatment of Pseudomonas Aeruginosa

Alipour, M., & Suntres, Z. E. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.13 · Cited by 26 · see citing works

Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues

Siafaka, P. I., Bülbül, E. Ö., Miliotou, Α. N., Karantas, I. D., Okur, M. E., & Okur, N. Ü. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105381 · Cited by 23 · see citing works

Nanostructures for drug delivery: pharmacokinetic and toxicological aspects

Ciucă, A. G., Grecu, C. I., Rotărescu, P., Gheorghe, I., Bolocan, A., Grumezescu, A. M., Holban, A. M., & Andronescu, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00030-0 · Cited by 23 · see citing works

“Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges

Cao, J., Xu, Y., Zhang, J., Fang, T., Wu, F., Zhen, Y., Yu, X., Liu, Y., Li, J., & Wang, D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105648 · Cited by 24 · see citing works

DRUG-RESISTANT TUBERCULOSIS: RECENT APPROACH IN POLYMER BASED NANOMEDICINE

Shaji, J., & Shaikh, M. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2016v8i10.11295 · Cited by 21 · see citing works

State-of-the-art review of the application and development of various methods of aerosol therapy

Matuszak, M., Ochowiak, M., Włodarczak, S., Krupińska, A., & Doligalski, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121432 · Cited by 21 · see citing works

Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives

Sugianto, T. D., & Chan, H. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1078309 · Cited by 21 · see citing works

Storage stability of inhalable, controlled-release powder formulations of ciprofloxacin nanocrystal-containing liposomes

Khatib, I., Ke, W.-R., Cipolla, D. C., & Chan, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120809 · Cited by 20 · see citing works

Nanocarriers for Respiratory Diseases Treatment: Recent Advances and Current Challenges

Trapani, A., Gioia, S. D., Castellani, S., Carbone, A., Cavallaro, G., Trapani, G., & Conese, M. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329225817 · Cited by 19 · see citing works

Nanomedicine to advance the treatment of bacteria-induced acute lung injury

Su, R., Zhang, Y., Zhang, J., Wang, H., Luo, Y., Chan, H. F., Tao, Y., Chen, Z., & Li, M. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01770e · Cited by 18 · see citing works

Recent Patents in Pulmonary Delivery of Macromolecules

Ray, A., Mandal, A., & Mitra, A. K. (2015) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/1872211309666150729122231 · Cited by 18 · see citing works

Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration

Ye, T., Wu, Y., Shang, L., Deng, X., & Wang, S. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1482973 · Cited by 18 · see citing works

Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery

Mansour, H. M., Muralidharan, P., & Hayes, D. (2024) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2024.29117.mk · Cited by 17 · see citing works

An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration

Penoy, N., Delma, K. L., Avohou, T. H., Grignard, B., Évrard, B., & Piel, G. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122212 · Cited by 17 · see citing works

Particle surface coating for dry powder inhaler formulations

Huang, Y., Patil, C. D., Arte, K. S., Zhou, Q. T., & Qu, L. L. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2482052 · Cited by 16 · see citing works

Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description

Altube, M. J., Perez, N., Romero, E. L., Morilla, M. J., Higa, L. H., & Perez, A. P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123146 · Cited by 15 · see citing works

Highly efficient pulmonary delivery of levo-tetrahydropalmatine using γ-cyclodextrin metal-organic framework as a drug delivery platform

Nie, Q., Wang, C., Xu, H., Mittal, P., Naeem, A., Zhou, P., Li, H., Zhang, Y., Guo, T., Sun, L., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104296 · Cited by 13 · see citing works

Oral Administration of Nanoparticles-Based TB Drugs

Magalhães, J., Vieira, A. C. C., Santos, S. G., Pinheiro, M., & Reis, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00016-2 · Cited by 13 · see citing works

Nanoscale characterization of PEGylated phospholipid coatings formed by spray drying on silica microparticles

An, J., Forchheimer, D., Sävmarker, J., Brűlls, M., & Frenning, G. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.05.045 · Cited by 13 · see citing works

Theranostic Applications of Tailored Lipid-based Nanoparticles as Drug Delivery Systems for Cancer Treatment

Gupta, C., Yadav, H., Dhanwani, I., & Gulati, S. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c03503 · Cited by 13 · see citing works

Pentaglycine lipid derivates – rp-HPLC analytics for bioorthogonal anchor molecules in targeted, multiple-composite liposomal drug delivery systems

Wöll, S., Schiller, S., Bachran, C., Swee, L. K., & Scherließ, R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.052 · Cited by 12 · see citing works

Applications of Chitosan in Pulmonary Drug Delivery

Guan, X., & Zhang, W. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87932 · Cited by 11 · see citing works

Design and comprehensive characterization of dry powder inhalation aerosols of simvastatin DPPC/DPPG lung surfactant-mimic nanoparticles/microparticles for pulmonary nanomedicine

Encinas-Basurto, D., Acosta, M. F., Eedara, B. B., Fineman, J. R., Black, S. M., & Mansour, H. M. (2024) · RSC Advances · doi:10.1039/d4ra04947k · Cited by 9 · see citing works

Engineering nanoliposomal tiotropium bromide embedded in a lactose-arginine carrier forming Trojan-particle dry powders for efficient pulmonary drug delivery: A combined approach of in vitro-3D printing and in silico-CFD modeling

Salmanipour, S., Sokhansanj, A., Jafari, N., Hamishehkar, H., & Saha, S. C. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125171 · Cited by 10 · see citing works

Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis

Chen, W., Zhu, S., Qiang, X., Chen, S., Li, J., Wang, P., Tracey, K. J., & Wang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108649 · Cited by 9 · see citing works

Using Polar Ion-Pairs to Control Drug Delivery to the Airways of the Lungs

Dutton, B., Woods, A., Sadler, R., Prime, D., Barlow, D. J., Forbes, B., & Jones, S. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01166 · Cited by 9 · see citing works

Experimental Design Supported Liposomal Aztreonam Delivery: In Vitro Studies

Bhattacharyya, S., Sudheer, P., Das, K., & Ray, S. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.074 · Cited by 9 · see citing works

Oral drug delivery systems using core–shell structure additive manufacturing technologies: a proof-of-concept study

Zhang, J., Xu, P., Vo, A. Q., & Repka, M. A. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa037 · Cited by 8 · see citing works

Nanoparticles in Drug Delivery Systems

Castro, E., & Kumar, A. (2013) · CRC Press eBooks · doi:10.1201/b14802-4 · Cited by 8 · see citing works

Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery

Lalan, M. S., Tandel, H., Lalani, R., Patel, V., & Misra, A. R. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_9 · Cited by 8 · see citing works

The Significance of Nanoparticles in Medicine and Their Potential Application in Asthma

Tortorella, S. M., & Karagiannis, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_10 · Cited by 6 · see citing works

Nanoparticle-Based Pulmonary Immune Engineering

Trautmann-Rodriguez, M., & Fromen, C. A. (2025) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-082223-105117 · Cited by 6 · see citing works

Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review

Elella, M. H. A., Khatib, A. O. A., & Al-Obaidi, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050680 · Cited by 29 · see citing works

Recent advances in liposomal dry powder formulations: preparation and evaluation

Misra, A. R., Jinturkar, K., Patel, D. H., Lalani, J., & Chougule, M. B. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802652309 · Cited by 99 · see citing works

Solid Lipid Nanoparticles Based Dry Powder Inhalers for Enhanced Drug Delivery Against Lung Diseases

Onel, C., Tok, Y. P., & Özsoy, Y. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03513-4

Recent advances in inhalable liposomes for treatment of pulmonary diseases: Concept to clinical stance

Mehta, P. P., Ghoshal, D., Pawar, A., Kadam, S. S., & Dhapte-Pawar, V. S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101509 · Cited by 128 · see citing works

Inhalation Aerosol Phospholipid Particles for Targeted Lung Delivery

Eedara, B. B., Encinas-Basurto, D., Hayes, D., & Mansour, H. M. (2022) · CRC Press eBooks · doi:10.1201/9781003182566-17 · Cited by 2 · see citing works